Ginkgo Bioworks Holdings Inc. is a biotechnology company that operates as a platform for cell programming, delivering flexible, end-to-end services to address challenges across diverse markets including food and agriculture, pharmaceuticals, industrial and specialty chemicals. It organizes its operations into two primary segments: Cell Engineering, which provides biological R&D services and tools such as functional genomics, antibody developability, artificial intelligence models, and reconfigurable automation systems for research, development, and commercialization of engineered organisms; and Biosecurity, offering biomonitoring, bioinformatics support, and threat detection services to government and commercial clients through platforms like Canopy and Horizon. The company pioneers autonomous labs that automate experimental workflows, enabling scientists to program biology like software and accelerate biotech innovation in biopharma, agriculture, and industrial biotech. Founded in 2008 and headquartered in Boston, Massachusetts, Ginkgo Bioworks Holdings Inc. empowers organizations by replacing manual lab work with robotic systems, fostering efficiency in synthetic biology applications.